115 related articles for article (PubMed ID: 35532703)
1. Urinary pigment epithelium-derived factor as a marker of diabetic nephropathy in Egyptian patients with type 2 diabetes mellitus.
Fayed A; Rabiee A; El-Saadany O; Shaban M; Hesham D; Elghobary H; Hammad H; Fatthy M
Saudi J Kidney Dis Transpl; 2021; 32(5):1340-1347. PubMed ID: 35532703
[TBL] [Abstract][Full Text] [Related]
2. Urinary pigment epithelium-derived factor as a marker of diabetic nephropathy.
Chen H; Zheng Z; Li R; Lu J; Bao Y; Ying X; Zeng R; Jia W
Am J Nephrol; 2010; 32(1):47-56. PubMed ID: 20523035
[TBL] [Abstract][Full Text] [Related]
3. PEDF relieves kidney injury in type 2 diabetic nephropathy mice by reducing macrophage infiltration.
Li L; Zhang L; Chen D; Yu K; Gan H; Yang G
Endokrynol Pol; 2021; 72(6):643-651. PubMed ID: 34647607
[TBL] [Abstract][Full Text] [Related]
4. [Change and significance of serum pigment epithelium-derived factor in type 2 diabetic nephropathy].
Chen HB; Jia WP; Lu JX; Bao YQ; Li Q; Lu FD; Lu W; Yu HY; Xiang KS
Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1230-3. PubMed ID: 17686253
[TBL] [Abstract][Full Text] [Related]
5. The effects of calcium channel blockers on nephropathy and pigment epithelium-derived factor in the treatment of hypertensive patients with type 2 diabetes mellitus.
Tabur S; Oğuz E; Sabuncu T; Korkmaz H; Çelik H
Clin Exp Hypertens; 2015; 37(3):177-83. PubMed ID: 25050869
[TBL] [Abstract][Full Text] [Related]
6. Elevated circulating pigment epithelium-derived factor predicts the progression of diabetic nephropathy in patients with type 2 diabetes.
Hui E; Yeung CY; Lee PC; Woo YC; Fong CH; Chow WS; Xu A; Lam KS
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2169-77. PubMed ID: 25166721
[TBL] [Abstract][Full Text] [Related]
7. Serum pigment epithelium-derived factor: Relationships with cardiovascular events, renal dysfunction, and mortality in the Veterans Affairs Diabetes Trial (VADT) cohort.
Hunt KJ; Jenkins AJ; Fu D; Stevens D; Ma JX; Klein RL; Azar M; Zhang SX; Lopes-Virella MF; Lyons TJ;
J Diabetes Complications; 2019 Oct; 33(10):107410. PubMed ID: 31434620
[TBL] [Abstract][Full Text] [Related]
8. Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities.
Wang JJ; Zhang SX; Mott R; Knapp RR; Cao W; Lau K; Ma JX
Diabetes; 2006 Jun; 55(6):1678-85. PubMed ID: 16731830
[TBL] [Abstract][Full Text] [Related]
9. Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes.
Jenkins AJ; Zhang SX; Rowley KG; Karschimkus CS; Nelson CL; Chung JS; O'Neal DN; Januszewski AS; Croft KD; Mori TA; Dragicevic G; Harper CA; Best JD; Lyons TJ; Ma JX
Diabet Med; 2007 Dec; 24(12):1345-51. PubMed ID: 17971181
[TBL] [Abstract][Full Text] [Related]
10. Diabetic nephropathy: serum miR-9 confers a poor prognosis in and is associated with level changes of vascular endothelial growth factor and pigment epithelium-derived factor.
Xiao Y; Guo S; Zhang Y; Bian Z; Jia L; Hu Y; Chen J; Yin C; Li N; Zhang D; Zhao X; Wang J
Biotechnol Lett; 2017 Oct; 39(10):1583-1590. PubMed ID: 28667418
[TBL] [Abstract][Full Text] [Related]
11. Pigment epithelium-derived factor (PEDF) inhibits proximal tubular cell injury in early diabetic nephropathy by suppressing advanced glycation end products (AGEs)-receptor (RAGE) axis.
Maeda S; Matsui T; Takeuchi M; Yoshida Y; Yamakawa R; Fukami K; Yamagishi S
Pharmacol Res; 2011 Mar; 63(3):241-8. PubMed ID: 21115116
[TBL] [Abstract][Full Text] [Related]
12. Urinary podocyte-associated mRNA profile in Egyptian patients with diabetic nephropathy.
Fayed A; Rahman Tohamy IA; Kahla H; Elsayed NM; El Ansary M; Saadi G
Diabetes Metab Syndr; 2019; 13(5):2849-2854. PubMed ID: 31425946
[TBL] [Abstract][Full Text] [Related]
13. Protective Role of PEDF-Derived Synthetic Peptide Against Experimental Diabetic Nephropathy.
Ishibashi Y; Matsui T; Taira J; Higashimoto Y; Yamagishi S
Horm Metab Res; 2016 Sep; 48(9):613-9. PubMed ID: 27214310
[TBL] [Abstract][Full Text] [Related]
14. Genetic Regulation of Pigment Epithelium-Derived Factor (PEDF): An Exome-Chip Association Analysis in Chinese Subjects With Type 2 Diabetes.
Cheung CYY; Lee CH; Tang CS; Xu A; Au KW; Fong CHY; Ng KKK; Kwok KHM; Chow WS; Woo YC; Yuen MMA; Hai J; Tan KCB; Lam TH; Tse HF; Sham PC; Lam KSL
Diabetes; 2019 Jan; 68(1):198-206. PubMed ID: 30305369
[TBL] [Abstract][Full Text] [Related]
15. Relationship between pigment epithelium-derived factor (PEDF) and renal function in patients with diabetic retinopathy.
Matsuyama K; Ogata N; Matsuoka M; Shima C; Wada M; Jo N; Matsumura M
Mol Vis; 2008 May; 14():992-6. PubMed ID: 18523656
[TBL] [Abstract][Full Text] [Related]
16. Protective role of small pigment epithelium-derived factor (PEDF) peptide in diabetic renal injury.
Awad AS; Gao T; Gvritishvili A; You H; Liu Y; Cooper TK; Reeves WB; Tombran-Tink J
Am J Physiol Renal Physiol; 2013 Sep; 305(6):F891-900. PubMed ID: 23884140
[TBL] [Abstract][Full Text] [Related]
17. Investigation of angiotensin-1 converting enzyme 2 gene (G8790A) polymorphism in patients of type 2 diabetes mellitus with diabetic nephropathy in Pakistani population.
Younas H; Ijaz T; Choudhry N
PLoS One; 2022; 17(2):e0264038. PubMed ID: 35176079
[TBL] [Abstract][Full Text] [Related]
18. Delayed Treatment with a Small Pigment Epithelium Derived Factor (PEDF) Peptide Prevents the Progression of Diabetic Renal Injury.
Awad AS; You H; Gao T; Gvritishvili A; Cooper TK; Tombran-Tink J
PLoS One; 2015; 10(7):e0133777. PubMed ID: 26207369
[TBL] [Abstract][Full Text] [Related]
19. Estimation of transforming growth factor-beta 1 as a marker of renal injury in type II diabetes mellitus.
Ibrahim S; Rashed L
Saudi Med J; 2007 Apr; 28(4):519-23. PubMed ID: 17457470
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy.
Wang JJ; Zhang SX; Mott R; Chen Y; Knapp RR; Cao W; Ma JX
Am J Physiol Renal Physiol; 2008 May; 294(5):F1166-73. PubMed ID: 18322021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
